About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Drugs To Treat Resistant Tumors on the Anvil?

by Tanya Thomas on December 3, 2008 at 10:42 AM
Font : A-A+

 Drugs To Treat Resistant Tumors on the Anvil?

Certain tumors stubbornly refuse to be cowed down by previously available treatment methods. A team of scientists has now developed a new drug combination that has the potential to effectively deal with such a group of tumors.

While conducting a study, researchers from Dana-Farber Cancer Institute (DFCI), Massachusetts General Hospital (MGH) Cancer Center, and Beth Israel Deaconess Medical Center (BIDMC) Cancer Center found that combining two different kinase inhibitors - drugs that interfere with specific cell-growth pathways - led to significant tumor shrinkage in mice with lung cancer driven by mutations in the K-Ras gene.

Advertisement

In addition to their association with nearly 30 percent of cases of non-small-cell lung cancer, K-Ras mutations are involved in many cases of colon cancer and most pancreatic cancers, which are extremely resistant to treatment.

"Finding a way to effectively treat K-Ras-mutated cancers would be a huge advance in solid tumor oncology, since these mutations are common in several incurable cancers," Nature quoted Jeffrey Engelman, MD, PhD, of the MGH Cancer Center, one of the report's co-lead authors, as saying.
Advertisement

"Cancers with K-Ras mutations have been resistant to all targeted therapies to date, and it is exciting to learn that a combination of PI3K and MEK inhibitors, two families of drugs currently in clinical development, may be highly effective in these cancers," Engelman added.

The current study began with a focus on the PI3K signaling pathway, which is key to cell survival and known to control cellular motility and adhesion. PI3K mutations have caused tumor development in laboratory studies, but their role had not yet been studied in an animal model.

For the study, the researchers developed a transgenic mouse in which administration of the drug doxycycline induces the expression of cancer-associated PI3K mutations, leading to development of lung tumors. Treatment of those animals with an investigational PI3K inhibitor did lead to rapid tumor regression.

Since previous studies suggested that PI3K inhibition might also block K-Ras-induced tumor development, the researchers also tested the PI3K inhibitor in mice with K-Ras-stimulated tumors.

That treatment was ineffective, but since K-Ras also activates the MEK/ERK signaling pathway, the researchers treated the animals with an investigational MEK inhibitor and with a combination of both drugs.

Treatment with the MEK inhibitor alone caused only a modest reduction in tumor size, but combined treatment with both agents caused the K-Ras-stimulated lung tumors to virtually disappear.

"For several years we have known that K-Ras activates two major pathways - the PI3K pathway and the MEK/MAPK pathway - and that these pathways have many redundant functions in tumor growth and survival," says Lewis Cantley, PhD, of the BIDMC Cancer Center, one of the study's co-corresponding authors.

Inhibitors of both of these pathways are now in clinical trials, and in this paper we show that, while either agent alone has a minor effect on K-Ras-driven tumors in mice, combining inhibitors of both pathways eradicates these tumors with minimal toxicity," Cantley added.

The study appears online in Nature Medicine.

Source: ANI
TAN/L
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Sea Buckthorn
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Tumor Markers For Cancer Diagnosis and Prognosis Drugs Banned in India 

Recommended Reading
Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors ....
Bone Marrow Transplantation - Animation
Animation and slides providing graphic explanation of Bone Marrow Transplantation (BMT)/Stem Cell ....
Liver Cancer Treatment - Animation
Liver Cancer is the uncontrolled growth of cells in the liver. The present section provides a ......
Prostate Cancer - Animation
Interactive section of Medindia gives details regarding Prostate Cancer...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Tumor Markers For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use